Article
08 Jun 2026
Cassels On IP: June 2026
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in Canada
AUTHORS CONTENT
Article
07 May 2026
Employer Or Employee: Who Owns The Copyright?
Article
11 Mar 2026
Navigating Patentable Subject Matter Eligibility In Canada: Dusome Joins The Fold
Article
23 Dec 2025
Canadian Patent Law In Review 2025: Notable Decisions And Updates
Article
22 Oct 2025
Patent Infringement And Agricultural Biotechnology: Litigating With Urgency
Article
25 Sep 2025
The Tort Of Misuse Of Copyright: A Viable Defence
Article
30 Jul 2025
Patented Drug Pricing: The PMPRB Releases New Price-Review Guidelines
Article
03 Mar 2025
The New Due Care Roadmap: How To Avoid Deemed Expiry Or Abandonment Of Your Patent And Design Rights
Article
10 Feb 2025
The Patent Act Prevails – The Court Of Appeal Of Alberta Clarifies The Law On Limitation Periods For Patent Infringement Claims
Article
18 Jul 2024
Where Does Infringement Arise? Untangling The Knot Of Patent Infringement Limitation Periods
Article
27 Feb 2024
PMPRB "What We Learned Report" Released
Article
30 Jan 2024
Canadian Patent Law In Review 2023: Notable Cases And Trends For 2024
Article
22 Nov 2023
PMPRB Announces Scoping Paper For The Consultation On New Guidelines And Opens Stakeholder Registration For Policy Roundtables
Article
08 Nov 2023
PMPRB Announces Next Steps In Guidelines Consultation Process
Article
16 Oct 2023
Patented Medicine Prices Review Board Adopts Amended Interim Guidance On Pricing Of New Medicines
Article
13 Jul 2023
FCA Confirms The Importance Of Counsel's Role In Maintaining The Independence Of Experts
Article
22 May 2023
Bill C-47 Proposes To Amend Patent Act To Implement Cusma
Article
17 May 2023
FCA Confirms Test For Inducing Patent Infringement
Article
11 Jan 2023
Key Canadian Patent Law Decisions From 2022 And Some Predictions For 2023
Article
23 Dec 2022
Changes To List Of Comparator Countries Used To Assess Pricing Of Patented Medicines Affirmed On Appeal